natraliaeczema and psoriasis (LaCorium Health USA Inc.)
Welcome to the PulseAid listing for the natralia drug offered from LaCorium Health USA Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | LaCorium Health USA Inc. |
NON-PROPRIETARY NAME: | Sodium Borate, Graphite, Potassium Sulfate, and Sodium Chloride |
SUBSTANCE NAME: | SODIUM BORATE; GRAPHITE; POTASSIUM SULFATE; SODIUM CHLORIDE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2009-03-01 |
END MARKETING DATE: | 0000-00-00 |
natralia eczema and psoriasis HUMAN OTC DRUG Details:
Item Description | natralia eczema and psoriasis from LaCorium Health USA Inc. |
LABELER NAME: | LaCorium Health USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 6; 3; 12([hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g) |
START MARKETING DATE: | 2009-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43251-2241_24cc1f5a-9cdc-4dd3-bf59-33acd9cb6362 |
PRODUCT NDC: | 43251-2241 |
APPLICATION NUMBER: | |
Other SODIUM BORATE; GRAPHITE; POTASSIUM SULFATE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers: